Another large retrospective pharmacovigilance study revealed that patients with myocarditis are more often male (66%), having melanoma (40.7%) or lung cancer (32%), and are treated with anti-PD-1/PD-L1 as a single agent (69%) (12). Here, PDCD1 is linked to myocarditis.